Bausch Health Cos Quick Ratio 2012-2026 | BHC
Historical quick ratio values for Bausch Health Cos (BHC) over the last 10 years.
| Bausch Health Cos Quick Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
| 2026-03-31 | $4.38B | $4.53B | 0.97 |
| 2025-12-31 | $4.53B | $4.18B | 1.08 |
| 2025-09-30 | $4.65B | $4.79B | 0.97 |
| 2025-06-30 | $4.86B | $4.98B | 0.98 |
| 2025-03-31 | $4.12B | $4.26B | 0.97 |
| 2024-12-31 | $4.18B | $6.75B | 0.62 |
| 2024-09-30 | $3.70B | $4.51B | 0.82 |
| 2024-06-30 | $3.60B | $4.37B | 0.82 |
| 2024-03-31 | $3.76B | $4.41B | 0.85 |
| 2023-12-31 | $4.05B | $4.30B | 0.94 |
| 2023-09-30 | $3.78B | $4.22B | 0.89 |
| 2023-06-30 | $3.22B | $3.97B | 0.81 |
| 2023-03-31 | $3.02B | $3.92B | 0.77 |
| 2022-12-31 | $3.16B | $3.94B | 0.80 |
| 2022-09-30 | $2.95B | $3.83B | 0.77 |
| 2022-06-30 | $4.34B | $5.00B | 0.87 |
| 2022-03-31 | $4.79B | $4.77B | 1.00 |
| 2021-12-31 | $4.61B | $5.20B | 0.89 |
| 2021-09-30 | $4.27B | $5.44B | 0.79 |
| 2021-06-30 | $4.36B | $5.52B | 0.79 |
| 2021-03-31 | $4.32B | $4.90B | 0.88 |
| 2020-12-31 | $4.25B | $4.91B | 0.87 |
| 2020-09-30 | $4.45B | $4.73B | 0.94 |
| 2020-06-30 | $4.05B | $4.72B | 0.86 |
| 2020-03-31 | $4.38B | $4.89B | 0.90 |
| 2019-12-31 | $5.86B | $6.25B | 0.94 |
| 2019-09-30 | $3.21B | $3.74B | 0.86 |
| 2019-06-30 | $3.41B | $3.71B | 0.92 |
| 2019-03-31 | $3.26B | $3.94B | 0.83 |
| 2018-12-31 | $3.28B | $3.84B | 0.85 |
| 2018-09-30 | $3.77B | $4.16B | 0.91 |
| 2018-06-30 | $3.65B | $4.07B | 0.90 |
| 2018-03-31 | $3.68B | $3.99B | 0.92 |
| 2017-12-31 | $3.70B | $4.27B | 0.87 |
| 2017-09-30 | $4.87B | $4.73B | 1.03 |
| 2017-06-30 | $4.91B | $4.47B | 1.10 |
| 2017-03-31 | $4.22B | $4.25B | 0.99 |
| 2016-12-31 | $4.02B | $3.61B | 1.11 |
| 2016-09-30 | $4.37B | $3.90B | 1.12 |
| 2016-06-30 | $4.48B | $4.23B | 1.06 |
| 2016-03-31 | $4.91B | $4.60B | 1.07 |
| 2015-12-31 | $4.25B | $5.31B | 0.80 |
| 2015-09-30 | $5.80B | $4.65B | 1.25 |
| 2015-06-30 | $5.12B | $4.29B | 1.19 |
| 2015-03-31 | $15.19B | $3.10B | 4.91 |
| 2014-12-31 | $3.24B | $2.71B | 1.20 |
| 2014-09-30 | $3.48B | $3.14B | 1.11 |
| 2014-06-30 | $4.22B | $2.50B | 1.69 |
| 2014-03-31 | $3.00B | $2.56B | 1.17 |
| 2013-12-31 | $3.00B | $2.51B | 1.20 |
| 2013-09-30 | $2.77B | $2.85B | 0.97 |
| 2013-06-30 | $4.04B | $1.76B | 2.29 |
| 2013-03-31 | $1.86B | $1.65B | 1.13 |
| 2012-12-31 | $2.25B | $1.82B | 1.23 |
| 2012-09-30 | $1.30B | $1.16B | 1.12 |
| 2012-06-30 | $1.24B | $1.05B | 1.18 |
| 2012-03-31 | $1.16B | $0.96B | 1.21 |
| 2011-12-31 | $1.00B | $0.92B | 1.08 |
| 2011-09-30 | $0.84B | $0.86B | 0.97 |
| 2011-06-30 | $0.79B | $0.76B | 1.03 |
| 2011-03-31 | $1.01B | $0.66B | 1.53 |
| 2010-12-31 | $0.79B | $0.69B | 1.14 |
| 2010-09-30 | $1.01B | $0.85B | 1.19 |
| 2010-06-30 | $0.33B | $0.23B | 1.39 |
| 2010-03-31 | $0.24B | $0.21B | 1.16 |
| 2009-12-31 | $0.26B | $0.25B | 1.04 |
| 2009-09-30 | $0.18B | $0.22B | 0.80 |
| 2009-06-30 | $0.18B | $0.22B | 0.81 |
| 2009-03-31 | $0.41B | $0.23B | 1.77 |
| 2008-12-31 | $0.43B | $0.27B | 1.61 |
| 2008-09-30 | $0.35B | $0.19B | 1.84 |
| 2008-06-30 | $0.59B | $0.35B | 1.69 |
| 2008-03-31 | $0.67B | $0.39B | 1.71 |
| 2007-12-31 | $0.63B | $0.37B | 1.70 |
| 2007-09-30 | $0.53B | $0.23B | 2.30 |
| 2007-06-30 | $0.00B | $0.28B | 0.00 |
| 2007-03-31 | $1.00B | $0.74B | 1.35 |
| 2006-12-31 | $0.98B | $0.41B | 2.39 |
| 2006-09-30 | $0.85B | $0.27B | 3.09 |
| 2006-06-30 | $0.70B | $0.26B | 2.75 |
| 2006-03-31 | $0.63B | $0.26B | 2.39 |
| 2005-12-31 | $0.60B | $0.27B | 2.18 |
| 2005-09-30 | $0.47B | $0.21B | 2.27 |
| 2005-06-30 | $0.35B | $0.22B | 1.59 |
| 2005-03-31 | $0.21B | $0.19B | 1.10 |
| 2004-12-31 | $0.21B | $0.19B | 1.08 |
| 2004-09-30 | $0.22B | $0.25B | 0.87 |
| 2004-06-30 | $0.22B | $0.25B | 0.87 |
| 2004-03-31 | $0.23B | $0.23B | 1.02 |
| 2003-12-31 | $0.33B | $0.26B | 1.25 |
| 2003-09-30 | $0.32B | $0.34B | 0.94 |
| 2003-06-30 | $0.34B | $0.32B | 1.04 |
| 2003-03-31 | $0.24B | $0.34B | 0.69 |
| 2002-12-31 | $0.27B | $0.35B | 0.78 |
| 2002-09-30 | $0.29B | $0.22B | 1.34 |
| 2002-06-30 | $0.19B | $0.22B | 0.88 |
| 2002-03-31 | $0.51B | $0.17B | 3.04 |
| 2001-12-31 | $0.54B | $0.15B | 3.62 |
| 2001-09-30 | $0.15B | $0.21B | 0.72 |
| 2001-06-30 | $0.16B | $0.22B | 0.73 |
| 2001-03-31 | $0.15B | $0.25B | 0.60 |
| 2000-12-31 | $0.24B | $0.29B | 0.83 |
| 2000-09-30 | $0.49B | $0.07B | 7.30 |
| 2000-06-30 | $0.59B | $0.06B | 9.31 |
| 2000-03-31 | $0.57B | $0.06B | 9.11 |
| 1999-12-31 | $0.33B | $0.07B | 4.41 |
| 1999-09-30 | $0.08B | $0.05B | 1.69 |
| 1999-06-30 | $0.13B | $0.03B | 4.16 |
| 1999-03-31 | $0.13B | $0.03B | 4.13 |
| 1998-12-31 | $0.13B | $0.02B | 5.65 |
| 1998-09-30 | $0.05B | $0.03B | 1.82 |
| 1998-06-30 | $0.06B | $0.02B | 2.76 |
| 1998-03-31 | $0.05B | $0.02B | 2.60 |
| 1997-12-31 | $0.00B | 0.00 | |
| 1997-09-30 | $0.00B | 0.00 | |
| 1997-06-30 | $0.03B | $0.02B | 1.54 |
| 1997-03-31 | $0.02B | $0.02B | 1.26 |
| 1996-12-31 | $0.02B | $0.02B | 1.09 |
| 1996-09-30 | $0.02B | $0.03B | 0.85 |
| 1996-06-30 | $0.03B | $0.04B | 0.88 |
| 1996-03-31 | $0.00B | $0.00B | 0.00 |
| 1995-12-31 | $0.03B | $0.03B | 0.91 |
| 1995-09-30 | $0.00B | 0.00 | |
| 1995-06-30 | $0.00B | 0.00 | |
| 1995-03-31 | $0.00B | 0.00 | |
| 1994-12-31 | $0.01B | $0.01B | 1.01 |
| 1994-09-30 | $0.00B | 0.00 | |
| 1994-06-30 | $0.01B | $0.01B | 0.69 |
| 1994-03-31 | $0.00B | 0.00 | |
| 1993-12-31 | $0.00B | $0.01B | 0.00 |
| 1993-09-30 | $0.00B | $0.01B | 0.00 |
| 1992-12-31 | $0.00B | $0.01B | 0.00 |
| 1991-12-31 | $0.00B | $0.00B | 0.00 |
| 1991-03-31 | $0.00B | $0.00B | 0.00 |
| 1990-12-31 | $0.00B | $0.00B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $2.086B | $10.266B |
| Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $35.437B | 10.97 |
| BridgeBio Pharma (BBIO) | United States | $14.460B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $11.109B | 17.29 |
| Aspen Pharmacare (APNHY) | South Africa | $3.708B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.918B | 22.33 |
| Taysha Gene Therapies (TSHA) | United States | $1.290B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $0.924B | 7.28 |
| Personalis (PSNL) | United States | $0.630B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.451B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.210B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.052B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |